Related Experiment Video
Updated: Jun 2, 2026

Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
Postpartum factors and natural fibroid regression
Shannon K Laughlin1, Katherine E Hartmann, Donna D Baird
1Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Postpartum progestin use was linked to reduced fibroid regression. Further research is needed on progestin-only treatments during critical reproductive periods for uterine fibroids.
Area of Science:
- Reproductive Endocrinology
- Gynecology
- Women's Health
Background:
- Uterine fibroids are common benign tumors.
- Fibroid size often decreases after pregnancy and childbirth (involution).
- Factors influencing this natural fibroid regression are not fully understood.
Purpose of the Study:
- To identify factors that inhibit or enhance natural fibroid regression postpartum.
- To investigate the association between postpartum medication use and fibroid regression.
Main Methods:
- Prospective cohort study of 494 women with fibroids identified in early pregnancy.
- Ultrasound assessments repeated 3-6 months postpartum for 279 women.
- Logistic regression analysis to determine factors associated with significant fibroid regression (>50% volume reduction).
Main Results:
- Postpartum use of progestin-only medication was significantly associated with less fibroid regression (P = .01).
- No association was found between combined estrogen-progestin use and fibroid regression.
- Cesarean delivery, fever, and breastfeeding were not significantly associated with fibroid regression.
Conclusions:
- Postpartum progestin use may impede the natural regression of uterine fibroids.
- Findings align with existing research on progesterone's role in fibroid development.
- Further investigation into progestin-only treatments during critical reproductive phases is warranted.
Related Concept Videos
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Proliferative Phase
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Ovarian Cycle
Clot Retraction and Fibrinolysis
Regression Toward the Mean
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...